UA94036C2 - Bendamustine pharmaceutical compositions for lyophilisation - Google Patents

Bendamustine pharmaceutical compositions for lyophilisation

Info

Publication number
UA94036C2
UA94036C2 UAA200709242A UAA200709242A UA94036C2 UA 94036 C2 UA94036 C2 UA 94036C2 UA A200709242 A UAA200709242 A UA A200709242A UA A200709242 A UAA200709242 A UA A200709242A UA 94036 C2 UA94036 C2 UA 94036C2
Authority
UA
Ukraine
Prior art keywords
lyophilisation
bendamustine
pharmaceutical compositions
bendamustine pharmaceutical
present
Prior art date
Application number
UAA200709242A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джейсон Эдвард Бриттайн
Джо Крейг Франклин
Original Assignee
Сефалон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сефалон, Инк. filed Critical Сефалон, Инк.
Publication of UA94036C2 publication Critical patent/UA94036C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.
UAA200709242A 2005-01-14 2006-01-13 Bendamustine pharmaceutical compositions for lyophilisation UA94036C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64435405P 2005-01-14 2005-01-14

Publications (1)

Publication Number Publication Date
UA94036C2 true UA94036C2 (en) 2011-04-11

Family

ID=39055518

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200709242A UA94036C2 (en) 2005-01-14 2006-01-13 Bendamustine pharmaceutical compositions for lyophilisation

Country Status (3)

Country Link
CN (1) CN101119708B (en)
UA (1) UA94036C2 (en)
ZA (1) ZA200705793B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072777A1 (en) * 2008-03-26 2010-09-22 Cephalon Inc SOLID FORMS OF BENDAMUSTINE CHLORHYDRATE
WO2010036702A1 (en) * 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
UA102120C2 (en) * 2008-12-03 2013-06-10 Астеллас Дойчленд Гмбх Oral dosage forms of bendamustine
CA2753641C (en) * 2009-02-25 2014-09-16 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
CN101836962B (en) * 2009-03-20 2013-02-20 北京本草天源药物研究院 Method for preparing bendamustine hydrochloride freeze-dried powder injection
CN101606934B (en) * 2009-07-27 2011-09-28 江苏奥赛康药业有限公司 Bendamustine hydrochloride composition
CN101912369B (en) * 2010-07-29 2012-11-14 深圳万乐药业有限公司 Method for preparing bendamustine hydrochloride freeze-dried preparation
CN102375044B (en) * 2010-08-18 2015-04-08 重庆华邦胜凯制药有限公司 Method for analyzing related substance from hydrochloric acid bendamustine intermediate Z6
CN103351346A (en) * 2013-07-29 2013-10-16 东南大学 Preparation method of impurity HP1 in bendamustine hydrochloride
CN103989641A (en) * 2014-05-29 2014-08-20 四川汇宇制药有限公司 Preparation method of bendamustine hydrochloride composition for injection
CN105272920B (en) * 2014-07-17 2020-01-24 江苏先声药业有限公司 Bendamustine hydrochloride mannitol ester and preparation method and application thereof
CN108078931B (en) * 2017-12-12 2019-02-01 健进制药有限公司 A kind of bendamustine hydrochloride freeze-dried powder needle and preparation method thereof
CN108324691B (en) * 2018-04-11 2019-03-08 健进制药有限公司 A kind of injection Carmustine lyophilized preparation and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors

Also Published As

Publication number Publication date
ZA200705793B (en) 2008-09-25
CN101119708A (en) 2008-02-06
CN101119708B (en) 2014-12-24

Similar Documents

Publication Publication Date Title
TW200637614A (en) Bendamustine pharmaceutical compositions
EA201001143A1 (en) ACTIVATORS OF THE PERFORMERS "EXECUTORS" 3, 6 And 7
CY1119865T1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINS DISEASE
LTPA2017009I1 (en) Bruton tyrosine kinase inhibitors
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
ECSP109903A (en) DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
UY33616A (en) COMPOUNDS WITH IMIDAZOTRIAZINONA STRUCTURE
MX2007010996A (en) Novel liposome compositions.
MX2011010673A (en) Nanoparticle formulations and uses therof.
WO2009027644A3 (en) Compositions for the treatment of neoplastic diseases
CY1111433T1 (en) PHARMACEUTICAL PREPARED FORM
CL2007000789A1 (en) Malonamide derived compounds, gamma-secretase inhibitors; Preparation process; pharmaceutical composition; and its use in the treatment of Alzheimer's disease.
BR112012006283A2 (en) stabilized adamts13 formulation, method for manufacturing a stabilized adamts13 formulation, kit, and methods for treating or preventing a disease and for treating or preventing a stroke
EA200971107A1 (en) CATECHOLAMINE DERIVATIVES, USEFUL FOR THE TREATMENT OF PARKINSON'S Disease
DOP2007000053A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
MX2010000098A (en) Polycyclic guanine derivatives and use thereof.
NI201000033A (en) HETEROCYCLIC AMIDES USEFUL FOR THE TREATMENT OF CANCER AND PSORIASIS
WO2010014253A3 (en) Ant4 inhibitor compounds and methods of use thereof
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
EA201071183A1 (en) FREE CRYSTAL FORM MALE ORPETITA
MX2011011618A (en) Therapeutic agents 713.
CL2008001325A1 (en) Compounds derived from pyrazole-pyridinone; preparation process of said compounds; pharmaceutical composition that includes them; and its use to treat inflammation, paget disease, osteoarthritis, Alzheimer's, among other diseases.
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
NO20054723L (en) Treatment of proliferative diseases with epophilone derivatives and radiation
MY148355A (en) Crystal form of epothilone b and use in pharmaceutical compositions